Chima O Ohaegbulam, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 Parker Hill Ave, Converse 4, Roxbury Crossing, MA 02120 Phone: 617-754-6025 Fax: 617-754-6026 |
Eric J Woodard, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 Parker Hill Ave, Converse 4, Roxbury Crossing, MA 02120 Phone: 617-754-6576 Fax: 617-754-6420 |
Gerwin Neumann, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 125 Parker Hill Ave, Roxbury Crossing, MA 02120 Phone: 617-738-0671 |
News Archive
A team of scientists has discovered that D-aspartic acid is a novel neurotransmitter that could potentially be used in the fight against neurological diseases such as Parkinson's and schizophrenia.
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
Stephen Garcia's family is frantic. The auto body worker, just 32 years old, has been on a ventilator in a Los Angeles-area hospital for nearly two weeks, gravely ill with COVID-19, unresponsive — and unaware of the battle they're waging on his behalf.
A new study claims that severe COVID-19 is caused by a positive feedback loop triggered by systemic inflammation and mediated by abnormal gut permeability. This finding could potentially help open up new avenues of treatment.
Scientists have identified a gene critical to lung maturation in newborns and the production of surfactant, which lines lung tissues and prevents the lungs from collapsing.
› Verified 8 days ago